PDCD1 and neoplasm: Tumors use the PD-1/PD-L1 pathway to protect themselves from immune attack.57,273 Many tumors upregulate PD-L1 expression due to inflammatory signals, which are produced by activated T cells.273 This PD-L1 overexpression generates an immunosuppressive milieu, inhibiting T cell activation even when tumor antigens are present.